Effect of cyclooxygenase-2 inhibitor (celecoxib) on the infarcted heart in situ
about
sameAs
Combination effects of salvianolic acid B with low-dose celecoxib on inhibition of head and neck squamous cell carcinoma growth in vitro and in vivo.Drug insight: cyclo-oxygenase 2 inhibitors and cardiovascular risk--where are we now?Inhibition of cyclooxygenase-2 improves cardiac function after myocardial infarction in the mouse.
P2860
Effect of cyclooxygenase-2 inhibitor (celecoxib) on the infarcted heart in situ
description
2001 nî lūn-bûn
@nan
2001 թուականի Յուլիսին հրատարակուած գիտական յօդուած
@hyw
2001 թվականի հուլիսին հրատարակված գիտական հոդված
@hy
2001年の論文
@ja
2001年論文
@yue
2001年論文
@zh-hant
2001年論文
@zh-hk
2001年論文
@zh-mo
2001年論文
@zh-tw
2001年论文
@wuu
name
Effect of cyclooxygenase-2 inhibitor (celecoxib) on the infarcted heart in situ
@ast
Effect of cyclooxygenase-2 inhibitor (celecoxib) on the infarcted heart in situ
@en
Effect of cyclooxygenase-2 inhibitor (celecoxib) on the infarcted heart in situ
@nl
type
label
Effect of cyclooxygenase-2 inhibitor (celecoxib) on the infarcted heart in situ
@ast
Effect of cyclooxygenase-2 inhibitor (celecoxib) on the infarcted heart in situ
@en
Effect of cyclooxygenase-2 inhibitor (celecoxib) on the infarcted heart in situ
@nl
prefLabel
Effect of cyclooxygenase-2 inhibitor (celecoxib) on the infarcted heart in situ
@ast
Effect of cyclooxygenase-2 inhibitor (celecoxib) on the infarcted heart in situ
@en
Effect of cyclooxygenase-2 inhibitor (celecoxib) on the infarcted heart in situ
@nl
P2093
P356
P1433
P1476
Effect of cyclooxygenase-2 inhibitor (celecoxib) on the infarcted heart in situ
@en
P2093
P356
10.1159/000056109
P407
P50
P577
2001-07-01T00:00:00Z